HOME › DRUGS › BRINZOLAMIDE
ACTIVE SUBSTANCE / INN

BRINZOLAMIDE

Brand name(s): BRINZOLAMIDE; BRIMONIDINE TARTRATE, AZOPT, SIMBRINZA, Azopt, BRINZOLAMIDE
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA209406
NDA204251
ACTIVE SUBSTANCE
Brinzolamide
REGULATORS
FDA · EMA
SPONSORS / MAH
ALCON LABS INC, SANDOZ, WATSON LABS INC
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BRINZOLAMIDEANDA211914PADAGIS USDiscontinued
SIMBRINZANDA204251ALCON LABS INCPrescription
BRINZOLAMIDEANDA209406WATSON LABS INCPrescription
AZOPTNDA020816SANDOZPrescription
BRINZOLAMIDE; BRIMONIDINE TARTRATEANDA212137PERRIGO PHARMA INTERNATIONAL DACNone (Tentative Approval)
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AzoptNovartis Europharm LimitedAuthorised09/03/2000Glaucoma, Open-Angle;Ocular Hypertension

FULL INTELLIGENCE ON BRINZOLAMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →